Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Macrogen Inc.

Macrogen Inc. detailed financials by Barron's. View 038290 business summary and company performance, for a clear financial breakdown.

Bionano Genomics: Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...
Labroots

Unlocking the Genetic Code: Harnessing the Power of Human Genotyping Arrays for Accurate Polygenic Risk Score Analysis

Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
C&EN

Nonaqueous Oxidation in DNA Microarray Synthesis Improves the Oligonucleotide Quality and Preserves Surface Integrity on Gold and Indium Tin Oxide Substrates

Institute of Inorganic Chemistry, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria Leibniz-Institute for Food Systems Biology at the Technical University of Munich, ...

DelveInsight Business Research, LLP: Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

The DNA diagnostics market is experiencing robust growth, driven by the increasing prevalence of genetic disorders, infectious diseases, and cancer worldwide. Rising adoption of precision medicine ...
IEEE

A Novel Features-Driven Augmentation of DNA Methylation Microarrays to Enhance Meningioma Brain Tumors Classification using Transformer models

Accurate diagnosis and classification of Central Nervous System (CNS) tumors, particularly meningiomas, pose significant challenges, especially when using DNA methylation profiling data. Limited ...
contemporarypediatrics

Genetic testing reveals key CNVs in affected children

Study of 99 pediatric patients found clinically significant CNVs in 30% of cases, supporting CMA as a first-tier test for developmental delay and ID. Clinically significant CNVs were identified in 30% ...
GEN

Efficiency, Sustainability Drive Thermo Fisher’s New Microarray Data Analysis Solution

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...